Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001714899-24-000112
Filing Date
2024-04-18
Accepted
2024-04-18 16:05:24
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-18

Document Format Files

Seq Description Document Type Size
1 ARS fy2023denaliannualreport.pdf ARS 13626379
  Complete submission text file 0001714899-24-000112.txt   18089599
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38311 | Film No.: 24854333
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)